Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details)

v3.21.2
Loss Per Common Share - Schedule of Income (Loss) Per Common Share, Basic and Diluted (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income (loss) available to stockholders $ 1,466,697 $ (231,920) $ 3,633,035 $ (2,088,195)
Weighted average shares outstanding - basic 24,850,261 24,850,261 24,850,261 24,850,257
Effect of dilutive securities:        
Weighted average shares outstanding - Diluted 25,154,905 24,850,261 25,131,165 24,850,257
Net income (loss) per share - basic (in USD per share) $ 0.06 $ (0.01) $ 0.15 $ (0.08)
Net income (loss) per share - diluted (in usd per share) $ 0.06 $ (0.01) $ 0.14 $ (0.08)
Stock Options        
Effect of dilutive securities:        
Stock options 304,644 0 280,904 0
Anti-dilutive shares underlying stock options outstanding 777,296 2,536,664 777,296 2,555,097